Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.

Gao L, Yue MM, Davis J, Hyjek E, Schuger L.

Virchows Arch. 2014 Apr;464(4):495-503. doi: 10.1007/s00428-014-1559-9. Epub 2014 Feb 26.

PMID:
24570392
2.

β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.

Flavin RJ, Cook J, Fiorentino M, Bailey D, Brown M, Loda MF.

Am J Clin Pathol. 2011 May;135(5):776-82. doi: 10.1309/AJCPPC9EX1ZHMRMA.

3.
4.

Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.

Grzegorek I, Lenze D, Chabowski M, Janczak D, Szolkowska M, Langfort R, Szuba A, Dziegiel P.

Anticancer Res. 2015 Jun;35(6):3353-60.

PMID:
26026095
5.

Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.

Matsui K, Takeda K, Yu ZX, Valencia J, Travis WD, Moss J, Ferrans VJ.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):1002-9.

PMID:
10712355
6.

Clinical and molecular insights into lymphangioleiomyomatosis.

Steagall WK, Taveira-DaSilva AM, Moss J.

Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S49-66. Review.

PMID:
16457017
7.

Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex.

Schiavina M, Di Scioscio V, Contini P, Cavazza A, Fabiani A, Barberis M, Bini A, Altimari A, Cooke RM, Grigioni WF, D'Errico-Grigioni A.

Am J Respir Crit Care Med. 2007 Jul 1;176(1):96-8. Epub 2007 Apr 12.

PMID:
17431222
8.

Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.

Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S, Fukuchi Y, Hino O.

J Hum Genet. 2002;47(1):20-8.

PMID:
11829138
9.

[Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].

Kuhnen C, Preisler K, Müller KM.

Pathologe. 2001 May;22(3):197-204. German.

PMID:
11402850
10.

LAM cells biology and lymphangioleiomyomatosis.

Grzegorek I, Drozdz K, Podhorska-Okolow M, Szuba A, Dziegiel P.

Folia Histochem Cytobiol. 2013;51(1):1-10. doi: 10.5603/FHC.2013.001. Review.

11.

Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.

Valencia JC, Steagall WK, Zhang Y, Fetsch P, Abati A, Tsukada K, Billings E, Hearing VJ, Yu ZX, Pacheco-Rodriguez G, Moss J.

Chest. 2015 Mar;147(3):771-7. doi: 10.1378/chest.14-0380.

PMID:
25411763
12.

Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.

Steagall WK, Pacheco-Rodriguez G, Glasgow CG, Ikeda Y, Lin JP, Zheng G, Moss J.

Am J Pathol. 2013 Sep;183(3):938-50. doi: 10.1016/j.ajpath.2013.05.024. Epub 2013 Jul 16.

13.
14.

A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis.

Sato T, Seyama K, Kumasaka T, Fujii H, Setoguchi Y, Shirai T, Tomino Y, Hino O, Fukuchi Y.

J Intern Med. 2004 Aug;256(2):166-73. Review.

15.

Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.

Maruyama H, Seyama K, Sobajima J, Kitamura K, Sobajima T, Fukuda T, Hamada K, Tsutsumi M, Hino O, Konishi Y.

Mod Pathol. 2001 Jun;14(6):609-14.

16.
17.

Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Carsillo T, Astrinidis A, Henske EP.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6085-90.

18.

Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis.

Sun Y, Zhang E, Lao T, Pereira AM, Li C, Xiong L, Morrison T, Haley KJ, Zhou X, Yu JJ.

Horm Cancer. 2014 Oct;5(5):284-98. doi: 10.1007/s12672-014-0192-z. Epub 2014 Jul 29.

19.

Lymphangioleiomyomatosis and tuberous sclerosis complex.

Chorianopoulos D, Stratakos G.

Lung. 2008 Jul-Aug;186(4):197-207. doi: 10.1007/s00408-008-9087-5. Epub 2008 Apr 12. Review.

PMID:
18408969
20.

Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.

Ferrans VJ, Yu ZX, Nelson WK, Valencia JC, Tatsuguchi A, Avila NA, Riemenschn W, Matsui K, Travis WD, Moss J.

J Nippon Med Sch. 2000 Oct;67(5):311-29. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk